SPRYD7 and colorectal carcinoma: Via qPCR, SPRYD7 was found to be upregulated at the mRNA level in highly metastatic-to-liver KM12SM and to liver and lung highly metastatic KM12L4a CRC cells in comparison to their isogenic poorly metastatic KM12C CRC cells.